 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
|
|
MERGE HEALTHCARE ANNOUNCES FUSION AXIGATE™ ORDER IN FRANCE
Colmar General Hospital ( Colmar, France) acquires suite of Fusion aXigate™ software
Milwaukee, WI, May 9, 2007 –Merge Healthcare, (NASDAQ: MRGE; TSX: MRG), a leading medical imaging software and services provider, today announced that Colmar General Hospital has awarded the company a contract for the Fusion aXigate™ clinical information management platform and numerous associated software modules, which will create an enterprise-wide, information-based workflow in the hospital.
The contract represents a comprehensive revision of the 1,339-bed medical center’s image and information management systems, and includes an electronic patient record (EPR), order and prescription management, computerized prescription order, emergency management, bed and patient identity management, reporting tools, laboratory server and pathology.
Fusion aXigate™ is an advanced web-based solution for patient, medical and clinical process management, that unifies the entire healthcare enterprise by integrating information from many different, previously isolated systems. With its open, modular architecture, Fusion aXigate™ is designed to be scalable, enabling customers to add new functionality through plug-in modules.
By providing a folder-based approach to medical information management, Fusion aXigate™ displays relevant information to different healthcare professionals at the click of a button. Specialists can use a variety of modules in Fusion aXigate™ to incorporate clinical content into the patient database. This unique clinical content can be stored and accessed through a standard interface that provides a comprehensive portrait of medical images, diagnoses and test results from oncology, psychiatry, radiology, surgery and more.
"Our aim is to reorient the information management system around patient care," says Roland Santagelo, Executive at Colmar General Hospital. "Specifically, we want to improve tracking of patient care through an automated medical information system and increase productivity via overall computerization of information and image management functions. The Fusion aXigate™ solution, with its rich variety of software modules, meets all of these needs very well and we are pleased to work with Merge Healthcare in the Fusion aXigate™ implementation."
"After an intensive and thoughtful evaluation of their present and future needs, officials at Colmar General Hospital selected our Fusion aXigate™ solution,"saysVincent Leclerc, General Manager, Merge Healthcare France. "We’re delighted and honored that hospital officials here recognized the unique benefits of Fusion aXigate™ to help them with such a strategic project for increasing the quality of patient care and for streamlining workflow."
# # #
Merge Healthcare is a developer of medical imaging and clinical software applications and developmental tools that are on the forefront of medicine. We develop medical imaging software solutions that support end-to-end business and clinical workflow for radiology department and specialty practices, imaging centers and hospitals. Our software technologies accelerate market delivery for our OEM customers, while our end-user solutions improve our customers’ productivity and enhance the quality of the patient experience. For additional information, visit our website at www.merge.com.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
